The latest report by IMARC Group, titled “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the parenteral nutrition market report. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global parenteral nutrition market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Parenteral nutrition is a specialized form of nutrition therapy administered intravenously to patients who are unable to obtain adequate nutrition via the gastrointestinal tract. It provides essential nutrients such as carbohydrates, proteins, fats, vitamins, and minerals directly into the bloodstream, bypassing the digestive system. Parenteral nutrition is commonly used in patients with severe malnutrition, gastrointestinal disorders, or those undergoing surgical procedures that impair normal nutrient absorption. Additionally, it may be prescribed for critically ill patients or those with metabolic disorders who require precise control over nutrient intake. Parenteral nutrition plays a crucial role in supporting the nutritional needs of patients who cannot tolerate or absorb nutrients orally, helping to prevent complications associated with malnutrition and promoting recovery and overall health.

Get a Sample Copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample

Market Trends:

The global market is majorly driven by the increasing prevalence of chronic diseases, gastrointestinal disorders, and metabolic conditions. As these conditions impair normal nutrient absorption or tolerance, patients rely on parenteral nutrition to meet their nutritional needs and prevent malnutrition-related complications. Besides, advancements in medical technology and healthcare infrastructure enhance the accessibility and delivery of parenteral nutrition products and services, driving market growth. Improved formulations, administration techniques, and monitoring systems improve patient outcomes and facilitate the adoption of parenteral nutrition therapy in diverse healthcare settings. The demographic trends, such as an aging population and rising incidence of preterm births, increase the patient population in need of parenteral nutrition support.

Additionally, the expanding scope of parenteral nutrition beyond hospitals and acute care settings to home-based and long-term care environments drives market expansion. With a growing emphasis on patient-centered care and personalized nutrition solutions, the market for parenteral nutrition is expected to continue its upward trajectory, supported by advancements in medical science, healthcare delivery, and patient education. Moreover, the COVID-19 pandemic has further underscored the importance of nutritional support in critical care settings, driving awareness and adoption of parenteral nutrition as an essential component of comprehensive patient management strategies.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/parenteral-nutrition-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Aculife Healthcare Private Limited
• Braun Melsungen AG
• Baxter International Inc.
• Fresenius SE & Co. KGaA
• Grifols S.A.
• Otsuka Pharmaceutical Factory Inc.
• Pfizer Inc.
• Servona GmbH

Parenteral Nutrition Market Segmentation:

Our report has categorized the market based on region, nutrient type and end use.

Breakup by Nutrient Type:

• Carbohydrates
• Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins and Minerals

Breakup by End User:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145